This inventor holds 3 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Macclesfield, GB (2010 - 2011)
- Cambridge, GB (2022)
Company Filing History:
Years Active: 2010-2022
Title: Paul David Kemmitt: A Visionary Inventor in Pharmaceutical Innovations
Introduction: Paul David Kemmitt is an accomplished inventor based in Macclesfield, GB, known for his significant contributions to pharmaceutical innovations. With a total of three patents to his name, Kemmitt has been at the forefront of developing compounds aimed at treating various cell proliferative disorders and obesity.
Latest Patents: Among his recent innovations, Kemmitt holds patents for two notable compounds. The first is focused on tetracyclic heteroaryl compounds, which include pharmaceutical compositions for treating cell proliferative disorders. The patent specification details the various processes and intermediates used for their preparation, highlighting their potential in medicinal applications. The second patent pertains to pyrimido [4,5-B]-oxazines, which serve as DGAT inhibitors. These compounds are essential for tackling obesity, as they demonstrate efficacy in inhibiting DGAT-1, a key enzyme involved in fat metabolism.
Career Highlights: Paul David Kemmitt is currently associated with AstraZeneca AB, a multinational pharmaceutical company renowned for its innovative research and development. Throughout his career, Kemmitt has focused on advancing drug discovery and formulation, contributing valuable knowledge and experience to the field of pharmaceuticals.
Collaborations: Kemmitt collaborates with notable colleagues such as Alan Martin Birch and Jason Grant Kettle. Their teamwork in developing groundbreaking compounds has influenced the landscape of drug development, allowing for a more effective approach to managing various health conditions.
Conclusion: Paul David Kemmitt's inventive spirit and commitment to innovation have solidified his reputation as a leading figure in the pharmaceutical industry. His patents reflect his dedication to improving health outcomes through scientific discovery, and his ongoing collaborations promise further advancements in the treatment of challenging medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile